Emergence of Cumyl-PEGACLONE-related fatalities in the Northern Territory of Australia

  title={Emergence of Cumyl-PEGACLONE-related fatalities in the Northern Territory of Australia},
  author={Marianne Tiemensma and John David Rutherford and Timothy Scott and Steven B. Karch},
  journal={Forensic Science, Medicine and Pathology},
  pages={3 - 9}
Suspected unnatural or unexpected deaths in the Northern Territory of Australia are reportable to the coroner, and investigation of such cases typically includes a post-mortem examination with comprehensive toxicological screening. An autopsy case series of five Cumyl-PEGACLONE-related fatalities over a recent eighteen-month period is presented. Databases of the Northern Territory coroner’s office and the Royal Darwin Hospital Forensic Pathology Unit were searched to identify deaths related to… 
The Spicy Story of Cannabimimetic Indoles
Several laboratories applied computational chemistry methods to ultimately conclude that AAI and cannabinoid ligands could overlap within a common binding pocket but that WIN55212-2 primarily utilized steric interactions via aromatic stacking, whereas cannabinoid ligand required some electrostatic interactions, particularly involving the CB1 helix-3 lysine.
Synthetic cannabinoids in Europe – a review
  • Art
  • 2021


Four cases of death involving the novel synthetic cannabinoid 5F-Cumyl-PEGACLONE
Five cases of death involving its fluorinated analog, 5F-Cumyl-PEGACLONE, a recently emerged γ-carbolinone derived SC, are reported and the Toxicological Significance Score (TSS) was assigned to the compound.
Characteristics and circumstances of synthetic cannabinoid-related death
There was a high representation of relatively older decedents and of older males in particular, and while acute toxicity was the most common cause of death, cardiovascular disease was prominent.
A Fatality Involving Furanylfentanyl and MMMP, with Presumptive Identification of Three MMMP Metabolites in Urine.
The case of a 44-year-old male with a history of polysubstance abuse found deceased at his home address and items located within the vicinity of the deceased were found to contain furanylfentanyl and 2-methyl-4'-(methylthio)-2-morpholinopropiophenone, the first fatality in which MMMP has been detected.
Identification of a thermal degradation product of CUMYL-PEGACLONE and its detection in biological samples.
The thermal degradation product of CUMYLPEGACLONE is not one of its known metabolites, nor were any known metabolites detected during the thermal stability experiments, and has been detected in case samples, including post-mortem blood and urine, and residue found at a scene.
In vitro activity-profiling of Cumyl-PEGACLONE variants at the CB1 receptor: fluorination versus isomer exploration.
It is demonstrated that 5-fluorination of Cumyl-PEGACLONE is not linked to an intrinsically higher CB1 activation potential, and that the ethylbenzyl and n-propylphenyl isomers yield a strongly reduced CB1 activitation.
Assessing the toxicological significance of new psychoactive substances in fatalities.
The Toxicological Significance Score has been developed to support the risk assessment of NPS by allowing the role of a substance in deaths to be better assessed and classified.
Alcohol and Heart Disease in the Forensic Setting
The impacts of chronic high levels of ethanol consumption on cardiovascular structure and function are reviewed as they pertain to forensic pathology practice and brief reference to the collision between alcohol, cardiovascular disease, and forensically relevant scenarios is provided.
Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly
With the legalization of marijuana for medicinal purposes and/or recreational use in many countries, physicians should be alert to the possibility that the use of marijuana or its potent synthetic analogues might be the underlying cause of severe cardiovascular events and pathologies.